5Winkelstein JA, MarinoML, Lederman HM, at al. X-linked agammaglobulinemia: report on a United States registry of 201 patients [J]. Medicine (Baltimore) ,2006,85 (4) : 193-202.
7Conley ME, Broides A, Hernandez-Trujillo V, et al.Genetic analysis of patients with defects in early B-cell development [J].Immunol Rev, 2005,203 : 216-234.
9Plebani A, Soresina A, Rondelh R, et al. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study [J]. Clin Immunol, 2002,104: 221-230.
5Tsukada S, Saffran DC, Rawlings DJ, et al. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell, 1993, 72:279-290.
6Futatani T, Miyawaki T, Tsukada S, et al. Deficient ex-pression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood, 1998, 91:595-602
7Sideras P, Smith CIE. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv Immunol, 1995, 59:135-197.
8Yip KL, Chan SY, Ip WK, et aL Bruton's tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Hum Mutat, 2000, 15:385-388.
9Kanegane H, Futatani T, Wang Y, et al. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by tlow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol, 2001, 108: 1012-1020.
10Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr, 2002, 141:566-571.
